Operative delivery in women with benign uterine tumors
Keywords:benign uterine tumors, types of uterine leiomyoma, childbirth tactics, operative delivery
Objective of the study: to determine the role of operative delivery in the childbirth tactics for women with benign uterine tumors based on the identification of pathogenetically substantiated criteria for operative birth, to prevent obstetric and perinatal complications.
Materials and methods. In 110 women with uterine leiomyoma (LM) – 77 (70.0%) with one node (Group 1) and 33 (30.0%) with multiple nodes (Group 2) delivery tactics were defined. For this purpose, the type of LM, the location of the nodes relative to the placenta, complications of pregnancy, childbirth were revealed and analyzed.
Study results and discussion. The revealed coincidence of the location for І–ІV types LM nodes and placenta in 33 (42.86%) cases of one node and in 23 (69.70%) of multiple LM caused complications in the gestational period: placental insufficiency – in 44.16% and 45.45%; threat of interruption – in 30.30% and 5.96%; partial detachment of the placenta – in 18.18% and 27.27%; myomectomy – in 7.70% and 15.15%; fetal distress – in 31.17% and 36.36%; the threat of premature birth – in 24.68% and 24.24% of cases with the one node and multiple LM respectively and necessitated the determination of delivery tactics. Caesarean section was done in 42 (38.18%) cases: in 28 (36.36%) women with one node and in 14 (42.42%) with multiple nodes. The tendency to a higher frequency of operative delivery with multiple LM is due to the greater frequency of coincidence of the nodes location and placenta and pregnancy complications. Urgent delivery was made in 28.57% cases with one node of LM and in 14.28% with multiple nodes due to premature detachment of the placenta and bleeding, fetal distress. A smaller percentage of urgent operative delivery is due to an increase frequency of elective caesarean section for LM.
Conclusions. The coincidence of II–IV types LM node/nodes and placenta location is considered to be a pathogenetic factor in placental insufficiency, placental abruption in the gestational period and during childbirth, bleeding, fetal distress, and the prognostic criterion for obstetric and perinatal complications. Among pathogenetically substantiated criteria for operative delivery along with other factors consider: coincidence of the location of the placenta and II–IV types LM node or multiple І-ІV types LM nodes; myomectomy. Presence of these criteria determines the planned caesarean section by the method of choice in the childbirth tactics for women with LM.
- Khan, A.T., Shehmar, M., Gupta, J.K. “Uterine fibroids: current perspectives.” In J Womens Health 6.2 (2014): 95-114. DOI: 10.2147/IJWH. S51083
- Donnez, J., Dolmans, M.M. ”Uterine fibroid management: From the present to the future.” Hum Reprod Update 22.6 (2016): 665–86. DOI: 10.1093/hum upd/dmw 023
- Shapovalova, A.I. “Uterine fibroid and reproduction.” Journal of Obstetrics and Women’s Diseases 68.1 (2019): 93–101. DOI: 10.17816/JOWD68193-101
- Safarova, S.M. “Morphological characteristics of uterine fibroids among women of reproductive age.” Journal of Obstetrics and Women’s Diseases 66.1 (2017): 27–31. DOI: 10.17816/JOWD66127-31
- Torok, P., Poka, R. “Diagnosis and treatment of uterine myoma.” Orv Hetil 157.21 (2016): 813–9. DOI: 10.1556/650.2016.30435
- Laughlin-Tommaso, S.K. “Alternatives to hysterectomy: management of uterine fibroids.” Obstet Gynecol Clin North Am 43.3 (2016): 397–413. DOI: 10.1016/ j.ogc.2016.04.001
- Semeniak, A.V., Yuzko, O.M., Nitsovych, I.R. “Uterine leiomyoma and pregnancy.” Neonatology, surgery and perinatal medicine 8.2 (2018): 93–8. DOI: 10.24061/2413-4260/VIII.2.28.2018.14
- Makarenko, M.B., Govseev, D.O., Zhayvoronok, S.A., et al. “Peculiarities of the course of pregnancy, childbirth and postpartum period in pregnant women with uterine leiomyoma.” Women’s health 2 (2015): 111–3.
- Podolskyi, Vl.V. “Pregnancy outcomes, deliveries, obstetrical and perinatal complications in women with leyomyoma and oncomarkersmin placenta.” Neonatology, surgery and perinatal medicine 2 (2015): 71–7.
- Klassen, A.A., Tyapaev, Y.V., Cheremisin, A.E., Grudkin, A.A. “Pregnancy and childbirth in women with uterine myoma.” Orenburg Medical Bulletin 3.6 (2015): 12–5.
- Kaminskiy, V.V., Prokopovych, E.V. “New aspects in the treatment of uterine leiomyoma associated with endometriosis.” Women’s health 7 (2017): 32–5.
- Donnez, J., Tatarchuk, T.F., Bouchard, P., et al. “Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery.” N Engl J Med 336 (2012): 409–20. DOI: 10.1056/NEJMoa1103182
- Vdovichenko, Y.P., Golianovsky, O.V., Lopushin I.V. “Uterine leiomyoma: aetiopathogenesis, preventive care, diagnostics and treatment (literature review).” Women’s health 3 (2012): 52–61.
- Veropotvelyan, P.N., Veropotvelyan, N.P., Tsekhmistrenko, I.S., Bondarenko, A.A. “The modern concept of uterine cancer and its treatment.” Women’s health 7 (2016): 16–22.
- Avramenko, N.V., Barkovskyi, D.E., Kabachenko, O.V., Letcin, D.V. “Contemporary views of the reproductologist on etiopathogenesis and treatment of uterine leiomyoma.” Zaporizhzhya Medical Journal 19.3 (2017): 381–6. DOI: 10.14739/2310-1210.2017.3.100953.
- Mavrelos, D., Ben-Nagi, J., Holland, T., et al. “The natural history of fibroids.” Ultrasound Obstet Gynecol 35 (2010): 238–42. DOI: 10/1002/uog.7482
- Tusupkaliyev, A., Tuitebayeva, S., Nurken, A., et al. “Uterine rupture during pregnancy after laparoscopic myomectomy.” J Clin Med Kaz 1.43 (2017): 56–8. DOI: 10.23950/1812-2892-JCMK-00372.
- AAGL Practice Report. “Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas.” J Minim Invasive Gynecol 19.2 (2012): 152–71. DOI: 10.1016/ j.jmig.2011.09.005
How to Cite
Copyright (c) 2019 Василь Сергійович Ольшевський, О. В. Ольшевська
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.